Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

CureVac announces resolution of patent litigation with Pfizer/BioNTech

Drug price fixation: Sandoz to pay $275 million to settle case

Ruchika Sharma20 Feb 2025 4:24 PM IST

Sandoz has agreed to pay $275 million to settle claims that it conspired with competitors to fix prices illegally.Attorneys representing the...

Siemens sells 2 percent stake in Siemens Healthineers, raises around USD 1.5 billion

Ruchika Sharma20 Feb 2025 3:27 PM IST

Siemens, a German engineering giant has successfully raised approximately 1.45 billion euros ($1.5 billion) by selling a stake in its healthcare...

AstraZeneca Imfinzi gets USFDA priority review

USFDA issues 7 minor observations for Orchid Pharma Alathur facility

Ruchika Sharma20 Feb 2025 2:30 PM IST

New Delhi: Orchid Pharma Ltd., a vertically integrated pharmaceutical company, has received seven minor observations from the U.S. Food and...

Telangana: Illegally stocked drugs worth Rs 6.70 lakhs seized from unlicensed godown

Ruchika Sharma20 Feb 2025 1:30 PM IST

Telangana: In a recent raid conducted on an unlicensed godown in Telangana, the State Drugs Control Administration seized illegally stocked...

USFDA grants priority review to Sanofi-Regeneron Dupixent for bullous pemphigoid

Ruchika Sharma20 Feb 2025 12:30 PM IST

Paris: Sanofi has announced that the US Food and Drug Administration (FDA) has accepted for priority review the supplemental biologics license...

Boehringer, Click Therapeutics investigational prescription digital therapeutic meets primary endpoint in study for schizophrenia

Boehringer Ingelheim gets USFDA priority review for Zongertinib for HER2 (ERBB2)-mutant advanced non-small cell lung cancer treatment

Ruchika Sharma20 Feb 2025 11:30 AM IST

Ingelheim: Boehringer Ingelheim has announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to its new drug...

Unichem Labs Roha facility gets 3 USFDA observations

Aurobindo Pharma USA New Jersey warehouse gets USFDA OAI status

Ruchika Sharma20 Feb 2025 10:23 AM IST

Hyderabad: Aurobindo Pharma has announced that the United States Food and Drug Administration (US FDA) had conducted an inspection at one of the ...

Imbruvica gets positive EMA Committee opinion for untreated mantle cell lymphoma eligible for Stem Cell Transplant: Janssen-Cilag International

JnJ to resume US VARIPULSE cases

Ruchika Sharma20 Feb 2025 9:30 AM IST

New Brunswick: Johnson & Johnson will resume the limited market release of VARIPULSE in the United States after a comprehensive...

Indian shares end flat as financials offset declines in pharma, IT

Ruchika Sharma19 Feb 2025 5:20 PM IST

Benchmark indexes of India closed flat on Wednesday as gains in heavyweight financial countered losses in the pharmaceutical and IT stocks. Investor...

Cipla Bommasandra facility gets VAI classification from USFDA

Cipla completes investment of ZAR 900 million in South Africa subsidiary

Ruchika Sharma19 Feb 2025 4:56 PM IST

Mumbai: Cipla Limited has announced that the Company has completed an investment of approx. ZAR 900 million in Cipla Medpro South Africa...

Gland Pharma gets USFDA okay for Norepinephrine Bitartrate in 5% Dextrose Injection Bags

Innocan Pharma gets patent in India for Liposomal CBD Injection

Ruchika Sharma19 Feb 2025 2:30 PM IST

Israel: Innocan Pharma Corporation has announced that it has been granted a patent in India covering a prolonged-release pharmaceutical...

Trodelvy plus Keytruda effective for aggressive breast cancer type: Gilead Sciences

Gilead new drug applications for twice-yearly Lenacapavir for HIV Prevention accepted by USFDA under priority review

Ruchika Sharma19 Feb 2025 1:30 PM IST

Foster City: Gilead Sciences, Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok